print

Country Report

Japan Flag Dermatologicals in Japan

| Pages: 34

Price: US$900

About this Report

Executive Summary

TRENDS

  • Retail value sales of dermatologicals in Japan increased by 1% in current terms in 2013. Hair loss treatments remained the largest category in terms of retail value sales. The category’s steady growth turned negative in 2012 due to the negative growth of RiUP by Taisho Pharmaceutical Co Ltd, the largest brand in hair loss treatments compared to the significant sales increase of the brand in 2011. The remarkable performance was because of research findings by the Japanese Dermatological Association that certified the effectiveness of the key active ingredient in RiUP. Therefore, compared to 2012, sales of hair loss treatments recovered in 2013. While men’s hair loss treatments accounted for the majority of the total sales, women’s hair loss treatments expanded its value share in 2013 with several new products launches. In addition to women in middle-age and above, an increasing number of young women in their 30s are using hair loss treatment products for prevention purposes.

COMPETITIVE LANDSCAPE

  • Taisho Pharmaceutical Co Ltd remained the top player in dermatologicals. Its brand RiUP continued to dominate hair loss treatments, with a retail value share of 48% in 2013. The company launched an aerosol version of RiUP in December 2012 to meet the needs of young consumers in their 20s and 30s. Kao Corp’s Success ranked second. Compared to RiUP, Success is popular among younger consumers because of its affordable pricing. Other players actively promoted women’s hair loss treatments in 2013. Bathclin Corp launched three scalp care sprays for women from its hair loss treatments brand Mouga in February 2013. Lion Corp launched its first women’s hair loss treatments product, Fleuria, in June 2013, which is only available online. RiUP also offers a hair loss treatments product for women, RiUP Regenne, although its retail value sales remained low in 2013.

PROSPECTS

  • Dermatologicals is expected to register a CAGR of 1% at constant 2013 prices over the forecast period. Cold sore treatments is expected to remain the fastest growing category but account for only 4% of total retail value sales of dermatologicals in 2018. Retail value sales of hair loss treatments are expected to grow steadily, driven by growing demand among female consumers. More products marketed for female hair loss treatments are expected to be introduced over the forecast period. Topical antifungals is another promising category – the success of Rohto’s Mentholatum Exive highlighted demand for women’s athlete’s foot treatments.

TRENDS

  • Retail value sales of dermatologicals in Japan increased by 1% in current terms in 2013. Hair loss treatments remained the largest category in terms of retail value sales. The category’s steady growth turned negative in 2012 due to the negative growth of RiUP by Taisho Pharmaceutical Co Ltd, the largest brand in hair loss treatments compared to the significant sales increase of the brand in 2011. The remarkable performance was because of research findings by the Japanese Dermatological Association that certified the effectiveness of the key active ingredient in RiUP. Therefore, compared to 2012, sales of hair loss treatments recovered in 2013. While men’s hair loss treatments accounted for the majority of the total sales, women’s hair loss treatments expanded its value share in 2013 with several new products launches. In addition to women in middle-age and above, an increasing number of young women in their 30s are using hair loss treatment products for prevention purposes.

COMPETITIVE LANDSCAPE

  • Taisho Pharmaceutical Co Ltd remained the top player in dermatologicals. Its brand RiUP continued to dominate hair loss treatments, with a retail value share of 48% in 2013. The company launched an aerosol version of RiUP in December 2012 to meet the needs of young consumers in their 20s and 30s. Kao Corp’s Success ranked second. Compared to RiUP, Success is popular among younger consumers because of its affordable pricing. Other players actively promoted women’s hair loss treatments in 2013. Bathclin Corp launched three scalp care sprays for women from its hair loss treatments brand Mouga in February 2013. Lion Corp launched its first women’s hair loss treatments product, Fleuria, in June 2013, which is only available online. RiUP also offers a hair loss treatments product for women, RiUP Regenne, although its retail value sales remained low in 2013.

PROSPECTS

  • Dermatologicals is expected to register a CAGR of 1% at constant 2013 prices over the forecast period. Cold sore treatments is expected to remain the fastest growing category but account for only 4% of total retail value sales of dermatologicals in 2018. Retail value sales of hair loss treatments are expected to grow steadily, driven by growing demand among female consumers. More products marketed for female hair loss treatments are expected to be introduced over the forecast period. Topical antifungals is another promising category – the success of Rohto’s Mentholatum Exive highlighted demand for women’s athlete’s foot treatments.

Samples (FAQs about samples):

doc_pdf.png Sample Medicated Skin Care Market Research Report

doc_excel_table.png Sample Medicated Skin Care Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Japan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Japan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Japan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Japan?
  • What are the major brands in Japan?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Dermatologicals in Japan - Category Analysis

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

CATEGORY DATA

  • Table 1 Sales of Dermatologicals by Category: Value 2008-2013
  • Table 2 Sales of Dermatologicals by Category: % Value Growth 2008-2013
  • Table 3 NBO Company Shares of Dermatologicals: % Value 2009-2013
  • Table 4 LBN Brand Shares of Dermatologicals: % Value 2010-2013
  • Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2010-2013
  • Table 6 Forecast Sales of Dermatologicals by Category: Value 2013-2018
  • Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2013-2018

Dermatologicals in Japan - Company Profiles

Daiichi Sankyo Healthcare Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 1 Daiichi Sankyo Healthcare Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 2 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2013

Sato Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 3 Sato Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Sato Pharmaceutical Co Ltd: Competitive Position 2013

Taisho Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 5 Taisho Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Taisho Pharmaceutical Co Ltd: Competitive Position 2013

Takeda Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 7 Takeda Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Takeda Pharmaceutical Co Ltd: Competitive Position 2013

Consumer Health in Japan - Industry Context

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

CATEGORY DATA

  • Table 8 Sales of Dermatologicals by Category: Value 2008-2013
  • Table 9 Sales of Dermatologicals by Category: % Value Growth 2008-2013
  • Table 10 NBO Company Shares of Dermatologicals: % Value 2009-2013
  • Table 11 LBN Brand Shares of Dermatologicals: % Value 2010-2013
  • Table 12 LBN Brand Shares of Hair Loss Treatments: % Value 2010-2013
  • Table 13 Forecast Sales of Dermatologicals by Category: Value 2013-2018
  • Table 14 Forecast Sales of Dermatologicals by Category: % Value Growth 2013-2018

Segmentation

This market research report includes the following:

  • Dermatologicals
    • Medicated Shampoos
    • Topical Antifungals
    • Vaginal Antifungals
    • Hair Loss Treatments
    • Nappy (Diaper) Rash Treatments
    • Antiparasitics/Lice (Head and Body) Treatments
    • Antipruritics
    • Paediatric Dermatologicals
    • Cold Sore Treatments
    • Haemorrhoid Treatments
    • Topical Allergy Remedies/Antihistamines
    • Topical Germicidals/Antiseptics

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market Sizes
  • Company Shares
  • Brand Shares
  • Distribution
  • Pricing
  • Herbal/Traditional vs Standard

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

print

Recently Viewed Items more ›

    Want to find out more about this report?

    If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!